Companion Diagnostics Programming Set to Return at CHI’s Next Generation Dx Summit 2013 in August

NEEDHAM, Mass. - April 18, 2013 - PRLog -- Cambridge Healthtech Institute (CHI) is pleased to announce its annual Companion Diagnostics program that takes place at the annual Next Generation Dx Summit: Moving Assays to the Clinic will return to Washington, DC, on August 20-22, 2013.  This year’s event includes a lot more scientific presentations for delegates choose from and a bigger exhibit/poster hall.  Last year’s attendance peaked at over 600 delegates from 25 countries.

August 20-21:  Companion Diagnostics: From Biomarker Validation to Regulatory Approval

August 21-22:  Companion Diagnostics: Advancing Technologies and Winning Reimbursement

Both conferences bring together a well-respected faculty and a plenary keynote discussion hosted by Andrew C. Fish, Executive Director, AdvaMedDx.  Mr. Fish’s presentation, entitled “Perspectives on Evaluating Diagnostics for Reimbursement,” will take place on Wednesday, August 21.  

For more information and to register, visit http://www.NextGenerationDx.com.

To inquire about sponsoring and/or exhibiting, contact Joseph Vacca, 781-972-5431, jvacca@healthtech.com.

Writers and editors are invited to attend.  To request a press pass, contact Lisa Scimemi at lscimemi@healthtech.com.

About the Next Generation Dx Summit (NextGenerationDx.com)

(Enabling Point-of-Care Diagnostics, Cancer Molecular Markers to Guide Therapy, Molecular Diagnostics for Infectious Disease, Companion Diagnostics, Commercialization of Molecular Diagnostics, Molecular Profiling of Circulating Tumor Cells) is designed to bring together all of the major players in the evolving areas of diagnostics. This year, we have assembled an impressive faculty of speakers from industry, government, and leading academic institutions. This meeting will showcase improvements in technology research and development with an emphasis on applications in the clinic and commercialization. Plan to hear what industry leaders are saying about future market opportunities and network with your peers this August 20-22 in Washington, DC.

About Cambridge Healthtech Institute (chicorporate.com)

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech’s Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.